Evaluating strategies for the treatment of cerebral cavernous malformations
about
Uncommon cavernous malformation of the optic chiasm: a case reportRho kinase as a target for cerebral vascular disordersKLF4 is a key determinant in the development and progression of cerebral cavernous malformations.Pediatric cerebral cavernous malformations: Genetics, pathogenesis, and management.Exceptional aggressiveness of cerebral cavernous malformation disease associated with PDCD10 mutationsVariations of CITED2 are associated with congenital heart disease (CHD) in Chinese population.Combined HMG-COA reductase and prenylation inhibition in treatment of CCM.Exophytic hypothalamic cavernous malformation mimicking an extra-axial suprasellar mass.Strategy for identifying repurposed drugs for the treatment of cerebral cavernous malformation.Symptomatic spinal cavernous malformations: indication for microsurgical treatment and outcome.Sulindac metabolites decrease cerebrovascular malformations in CCM3-knockout mice.The cerebral cavernous malformation pathway controls cardiac development via regulation of endocardial MEKK3 signaling and KLF expression.Vascular permeability in cerebral cavernous malformations.Stroke-related translational research.Varying clinical presentations of familial cerebral cavernous malformations (CCMs) and spinal cord cavernous malformations (SCCMs).Discovery of familial cerebral cavernous malformation in a Saudi population.Cerebral cavernous malformation proteins at a glance.Signaling pathways and the cerebral cavernous malformations proteins: lessons from structural biology.Miconazole protects blood vessels from MMP9-dependent rupture and hemorrhage.Brain cavernomas associated with en coup de sabre linear scleroderma: Two case reports.Beyond multiple mechanisms and a unique drug: Defective autophagy as pivotal player in cerebral cavernous malformation pathogenesis and implications for targeted therapies.KRIT1 loss of function causes a ROS-dependent upregulation of c-JunOxidative stress and inflammation in cerebral cavernous malformation disease pathogenesis: Two sides of the same coin.Micro-computed tomography in murine models of cerebral cavernous malformations as a paradigm for brain disease.
P2860
Q22001085-DDE32FBA-B669-4E10-B8C5-529FC667C6EEQ28081507-D42DE068-587D-4DC0-A1A2-455D71DE53AAQ30278010-AD563B00-AB6D-41CC-8D25-8638491969FEQ30363436-9B741FB2-13B5-4640-A1A0-9E54E1888D56Q30389638-4876F0D9-8221-402C-B2D9-33B348432DF0Q33645902-FFF01F7A-3B50-4243-ABCD-5D8CB37060E8Q33737847-2D3DA305-0302-41AF-AD95-60200318825CQ33816087-4B7CB275-402F-4044-9CB2-95D2B05E48A0Q35167117-495FC748-7285-4352-B264-72744CC6B9F1Q35220725-9B051FD2-E946-4CEC-92DA-FC618D4843FBQ35845857-A766F71B-B40B-4244-A4DC-8F326DB77559Q36109992-0BD8D1C0-1DD0-41A2-8F90-F62416D2D7D6Q36267403-4F721411-949E-4EB7-BBF4-78270666782DQ36953709-3C235C37-D26A-4FFC-9B37-EC1F4B49B708Q36985757-DF1AA124-E495-41FB-9B48-386963467A6CQ37345768-BE0AADC8-4353-4752-A827-2F0F67050E6EQ37583343-4730EBB3-649E-4F34-B5B4-372428E7DD21Q37722299-FEB6B742-CCAC-4F85-9229-34491A50700DQ37731171-F8C9FD69-0E25-4328-983D-C43BEC18E95FQ38266242-54F47490-2BEC-42CF-81C1-C865C9346506Q38824364-366431E5-7F8B-4D27-9D55-E1B1107A71C0Q38873324-64291140-0007-431A-BCA8-779DD0A3A972Q38957623-AF8DA0E5-37F0-4787-91F1-46A4C099C090Q40968561-BAFEAFC0-33C8-4004-85A5-A0A842E2F0E8
P2860
Evaluating strategies for the treatment of cerebral cavernous malformations
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Evaluating strategies for the treatment of cerebral cavernous malformations
@ast
Evaluating strategies for the treatment of cerebral cavernous malformations
@en
type
label
Evaluating strategies for the treatment of cerebral cavernous malformations
@ast
Evaluating strategies for the treatment of cerebral cavernous malformations
@en
prefLabel
Evaluating strategies for the treatment of cerebral cavernous malformations
@ast
Evaluating strategies for the treatment of cerebral cavernous malformations
@en
P2860
P1433
P1476
Evaluating strategies for the treatment of cerebral cavernous malformations
@en
P2093
Kevin J Whitehead
P2860
P356
10.1161/STROKEAHA.110.594929
P407
P433
P577
2010-10-01T00:00:00Z